Elevance Health Stock - Thursday technical snapshot with 200-day line in view
18.06.2026 - 21:41:21 | ad-hoc-news.de
Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 19:35 UTC. Details in the imprint.
Elevance Health (US2855211023) remains a core managed-care name in the Standard & Poor's 500 index as investors watch its valuation and chart levels. With no fresh corporate headlines on Thursday, the focus turns to the stock's technical picture and recent sector moves.
All news and key data on Elevance Health stock
Price charts, regulatory filings and corporate updates on Elevance Health stock can be found bundled in the ad-hoc-news topic overview and on the company's investor-relations pages.
How Elevance Health trades now
On Thursday, Elevance Health shares traded below recent peaks but remained comfortably within their 12-month range, with quote services showing prices just under the $400 mark. One data provider listed a last trade around $389.45, implying a modest pullback versus recent highs.
Alternative data platforms cite a spot level near $391.27, about 1.6% below the previous close, which underlines the usual small daily swings in managed-care stocks rather than a sharp dislocation. Against that backdrop, liquidity in Elevance Health shares stays robust by large-cap standards.
Chart levels and 200-day line
Technically, Elevance Health stock trades above lows seen during the 2024 volatility phase in U.S. health insurers, when regulatory headlines and medical-cost trends weighed on the group. Recent pricing near the high-$380s to low-$390s leaves the shares in the upper half of their broad 52-week range.
While the exact 200-day moving average level shifts daily, chart services place it notably below current trading, signaling that the medium-term trend remains intact for now. Any sustained move back toward that long-term average would likely be watched as a test of technical support by market participants monitoring the name.
Valuation and sector backdrop
Valuation screens show Elevance Health with a trailing or blended price-to-earnings ratio in the mid-teens, around 16.5 based on recent calculations. That leaves the stock trading below a recent sector peak multiple but clearly above the trough levels near 11 times earnings that were seen during episodes of stress.
Commentary gathered earlier in the current cycle described analyst sentiment toward Elevance Health as cautious but structurally confident, especially around the growing contribution from its Carelon health-services business. For the broader Standard & Poor's 500 health-care providers segment, the stock continues to represent a significant benchmark alongside peers like UnitedHealth and CVS Health.
The business behind the stock
Elevance Health makes its money primarily as a diversified health-benefits company in the United States, combining traditional health-insurance plans with health-services operations under the Carelon brand. The group serves commercial, government and specialty markets across multiple states through a mix of medical and pharmacy-benefit offerings.
Where the stock trades today
Elevance Health shares (US2855211023) trade on the New York Stock Exchange at about $389.45 as of 06/18/2026, 10:32 ET.
Key facts on Elevance Health stock
- Company: Elevance Health, Inc.
- ISIN: US2855211023
- WKN: A3DGN9
- Ticker: ELV
- Venue: NYSE
- Price (as of 06/18/2026, 10:32 ET): 389.45 USD
- Market cap: approximately 90,000,000,000 USD (as of 06/18/2026)
- Sector / Industry: Health Care - Managed Health Care
- Index membership: S&P 500
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
